Trial Profile
Prospective multicenter cohort study on the efficacy and safety of benralizumab in the treatment of severe asthma
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2018
Price :
$35
*
At a glance
- Drugs Benralizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 06 Aug 2018 New trial record